Frank Follmann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Pluripotent Stem Cells

High Fat Diet Induced

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Anja W Olsen, Ida Rosenkrands, Christina S Jacobsen, Hannah M Cheeseman, Max P Kristiansen, Jes Dietrich, Robin J Shattock, Frank Follmann
Immune signature of Chlamydia vaccine CTH522/CAF®01 translates from mouse-to-human and induces durable protection in mice. Nature communications 15 (1) (2024)
Anja Weinreich Olsen, Ida Rosenkrands, Martin J Holland, Peter Andersen, Frank Follmann
Publisher Correction: A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars. NPJ vaccines 7 (1) (2022)
Anja Weinreich Olsen, Ida Rosenkrands, Martin J Holland, Peter Andersen, Frank Follmann
A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars. NPJ vaccines 6 (1) (2021)